Ledger.Open graph →
SEC Form D · filed May 19, 2017

ONL Therapeutics, Inc

Offering
$4.3M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANN ARBOR, MI
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Mark K. Hooper · Ann Arbor, MIDirectorDavid N. Zacks · Ann Arbor, MIExec · DirectorJohn K. Freshley · Ann Arbor, MIExec · DirectorChristine Gibbons · Ann Arbor, MIDirectorJonathan R. Asmis · San Francisco, CAExec · DirectorRobert Seidel · BURBANK, CADirectorAlexander Korff · London, United KingdomDirectorJimmie A. Harvey, Jr · New York, NYExec · DirectorRafael Castilla · Ann Arbor, MIDirectorMalcolm A. Hoenlein · New York, NYDirectorJ. J. Lobell · New York, NYExec · DirectorArthur Loomis · Latham, NYExec · DirectorDan Feeney · Indianapolis, INDirectorRafael Castilla · Ann Arbor, MIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗